TrimMedium
The stock is in a Stage 4 decline with a confirmed sequence of lower highs and lower lows, trading below the 50 DMA and 200 DMA. While recent relief rallies have lifted price above the short-term EMAs, the longer-term downtrend persists and medium-term bias remains bearish. Short-term timing is neutral as price approaches the resistance zone around the falling 50 DMA and 200 DMA, so execution should be deferred until a test and potential rejection at resistance.
- ↑Q2 net interest income rose 8% YoY to $10.7M.
- ↑Q2 distributable earnings hit $9.0M ($0.37/sh vs $0.33 est).
- ↓Pre-securitization debt/equity was 2.3x, elevating leverage risk.
Full analysis →